Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotic Drugs

Author： Trollor Julian N.   Chen Xiaohua   Sachdev Perminder S.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.23, Iss.6, 2009-05, pp. : 477-492

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aripiprazole: Atypical neuroleptic malignant syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1377, 2011-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Neuroleptic malignant syndrome induced by atypical antipsychotics

By Farver Debra K  

Expert Opinion on Drug Safety, Vol. 2, Iss. 1, 2003-01 ,pp. : 21-35

Informa Healthcare

Access to resources Recommend Favorite

Genetic Predisposition to Neuroleptic Malignant Syndrome: Implications for Antipsychotic Therapy

By Kawanishi C.  

American Journal of PharmacoGenomics, Vol. 3, Iss. 2, 2003-01 ,pp. : 89-95

Adis International

Access to resources Recommend Favorite

Cognitive dysfunction in schizophrenia: comparison of treatment with a novel atypical antipsychotic agent versus conventional neuroleptic drugs

By Gallhofer B.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 200-201

Elsevier

Access to resources Recommend Favorite

Antidepressants and neuroleptic malignant syndrome

By Assion H.J.   Heinemann F.   Laux G.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 293-293

Elsevier

Access to resources Recommend Favorite